BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19796267)

  • 1. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
    Verneris MR; Miller JS
    Br J Haematol; 2009 Oct; 147(2):185-91. PubMed ID: 19796267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.
    Lin SJ; Kuo ML
    Pediatr Hematol Oncol; 2011 Nov; 28(8):640-6. PubMed ID: 21970456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56
    Shereck E; Day NS; Awasthi A; Ayello J; Chu Y; McGuinn C; van de Ven C; Lim MS; Cairo MS
    Innate Immun; 2019 Jul; 25(5):294-304. PubMed ID: 31068047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.
    Luevano M; Daryouzeh M; Alnabhan R; Querol S; Khakoo S; Madrigal A; Saudemont A
    Hum Immunol; 2012 Mar; 73(3):248-57. PubMed ID: 22234167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel myeloid-like NK cell progenitor in human umbilical cord blood.
    Perez SA; Sotiropoulou PA; Gkika DG; Mahaira LG; Niarchos DK; Gritzapis AD; Kavalakis YG; Antsaklis AI; Baxevanis CN; Papamichail M
    Blood; 2003 May; 101(9):3444-50. PubMed ID: 12506032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
    Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
    PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Cytomegalovirus Reactivation and Expansion of CD56
    Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dimensional analysis reveals distinct NK cell subsets but conserved response to stimulation in umbilical cord blood and adult peripheral blood.
    Buckle I; Johnson A; Rojas IL; Weinert V; Sester DP; Radford K; Guillerey C
    Eur J Immunol; 2023 Jun; 53(6):e2250118. PubMed ID: 37025016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
    Veluchamy JP; Heeren AM; Spanholtz J; van Eendenburg JD; Heideman DA; Kenter GG; Verheul HM; van der Vliet HJ; Jordanova ES; de Gruijl TD
    Cancer Immunol Immunother; 2017 Jan; 66(1):51-61. PubMed ID: 27783105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.
    Zhao X; Cai L; Hu Y; Wang H
    Front Immunol; 2020; 11():584099. PubMed ID: 33193399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.